A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
Clinical trial NCT05798520 · COMPLETED
Trial details
- NCT number
- NCT05798520
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2026-02-10
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.